Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Neoplasm Metastasis 40Lung Neoplasms 34Leukemia, Myeloid, Acute 34Breast Neoplasms 31Multiple Myeloma 25Carcinoma, Non-Small-Cell Lung 25Colorectal Neoplasms 23Prostatic Neoplasms 21Pancreatic Neoplasms 20Melanoma 17Carcinoma, Renal Cell 17Lymphoma 16Urinary Bladder Neoplasms 15Triple Negative Breast Neoplasms 15Ovarian Neoplasms 14Myelodysplastic Syndromes 14Burkitt Lymphoma 12Lymphoma, Large B-Cell, Diffuse 11Squamous Cell Carcinoma of Head and Neck 10Sarcoma 10Leukemia, Lymphocytic, Chronic, B-Cell 10Glioma 10Fallopian Tube Neoplasms 10Mouth Neoplasms 9Endometrial Neoplasms 9Carcinoma, Transitional Cell 9Carcinoma, Hepatocellular 9Carcinoma 9Oropharyngeal Neoplasms 8Laryngeal Neoplasms 8

Interventions

dinutuximab 2Vincristine 2Topotecan 2Thiotepa 2Stem Cell Transplantation 2Radiation 2Platinum 2Melphalan 2Isotretinoin 2Etoposide 2Doxorubicin 2Cyclophosphamide 2Cisplatin 2Carboplatin 21,2-diaminocyclohexaneplatinum II citrate 2sargramostim 1Transurethral Resection of Bladder 1Temozolomide 1Specimen Handling 1Razoxane 1Radiotherapy 1Proton Therapy 1Nuclear Medicine Department, Hospital 1Magnetic Resonance Spectroscopy 1Leukapheresis 1Irinotecan 1Hematopoietic Stem Cell Transplantation 1Dexrazoxane 1Congresses as Topic 1Colony-Stimulating Factors 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Ganglioneuroblastoma × Specimen Handling × 30 days × Clear all
NCT06172296 2026-06-03

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

National Cancer Institute (NCI)

Phase 3 Recruiting
478 enrolled
CNS

Neuroblastoma, Ganglioneuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡